Advertisement
Advertisement
U.S. markets close in 4 hours 39 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Co-Diagnostics, Inc. (CODX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
6.11-0.01 (-0.08%)
As of 11:20AM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Short-term KST

Short-term KST

Previous Close6.12
Open6.12
Bid6.07 x 800
Ask6.09 x 900
Day's Range6.03 - 6.23
52 Week Range3.66 - 11.82
Volume178,154
Avg. Volume363,465
Market Cap207.835M
Beta (5Y Monthly)-1.15
PE Ratio (TTM)4.31
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
129% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for CODX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Co-Diagnostics, Inc.
    VIR: Raising target price to $23.00VIR BIOTECHNOLOGY INC has an Investment Rating of SELL; a target price of $23.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
    Rating
    Fair Value
    Economic Moat
    7 days agoArgus Research
View more
  • PR Newswire

    Co-Diagnostics, Inc. to Present at 29th International Biodetection Technologies Virtual Conference

    Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx,"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be presenting this week at the 29th International Biodetection Technologies Conference, held virtually June 28-29, 2022.

  • PR Newswire

    Co-Diagnostics, Inc. to Present at Sidoti Summer Small Cap Virtual Conference

    Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx,"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that Dwight Egan, CEO, Brian Brown, CFO, and Andrew Benson, Head of Investor Relations, will present and host one-on-one meetings with investors at the Sidoti Summer Small Cap Virtual Investor Conference June 15-16, 2022.

  • ACCESSWIRE

    Sidoti's Summer Small Cap Virtual Conference

    * Presentation Times and Weblinks Released for Over 70 Presenting Companies * Wednesday and Thursday, June 15th-16th, 2022NEW YORK, NY / ACCESSWIRE / June 14, 2022 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day Summer Small Cap Virtual Conference taking place Wednesday and Thursday, June 15th-16th, 2022. The links can also be found at www.

Advertisement
Advertisement